{"id":"W4308523453","doi":"10.1158/1078-0432.ccr-22-2191","title":"Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Capecitabine; Internal medicine; Oncology; Medicine; Breast cancer; Triple-negative breast cancer; Basal (medicine); Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00110572,0.0003254543,0.0005646312,0.00009986819,0.0006815293,0.00003936029,0.0007238134,0.0001921402,0.002985795],"category_scores_gemma":[0.0003118792,0.0002954851,0.0002670783,0.0005094754,0.0006293321,0.00001041296,0.001330739,0.001001801,0.00003849055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004465947,"about_ca_system_score_gemma":0.001184303,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01199745,"about_ca_topic_score_gemma":0.005040977,"domain_scores_codex":[0.995615,0.0005431121,0.0006341869,0.001272804,0.001042312,0.0008925834],"domain_scores_gemma":[0.9976425,0.0004315717,0.0001795998,0.00079034,0.000605832,0.0003501585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02508905,0.00292625,0.6018983,0.00008622446,0.002647236,0.000179551,0.0009369839,0.0006772646,0.01916277,0.00007384171,0.185153,0.1611695],"study_design_scores_gemma":[0.007112105,0.001073833,0.9610224,0.00006431263,0.0001167407,0.000007540229,0.0006591314,0.0001718213,0.005671835,0.0008179828,0.02278889,0.0004933939],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747171,0.008312969,0.00002171599,0.006615866,0.001615741,0.0008591796,0.007083675,0.0000359925,0.0007377801],"genre_scores_gemma":[0.9875235,0.004176279,0.00008693476,0.0008088227,0.002529793,0.002284901,0.0003756924,0.00007882075,0.002135252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3591241,"threshold_uncertainty_score":0.9999498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07225856200408001,"score_gpt":0.4286964893067917,"score_spread":0.3564379273027116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}